Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD

American Journal of Kidney Diseases

Volumn 46, Issue 4, 2005, Pages 628-634

  Axelsson, Jonas ^a   Qureshi, Abdul Rashid ^a   Heimbürger, Olof ^a   Lindholm, Bengt ^a   Stenvinkel, Peter ^a   Bárány, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Chronic renal failure; End stage renal disease (ESRD); Epoetin; Fat mass; Inflammation; Leptin; Renal anemia

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FAT; FERRITIN; HEMOGLOBIN; INTERLEUKIN 6; LEPTIN; NEOPTERIN; PARATHYROID HORMONE; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; BODY WEIGHT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG SENSITIVITY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; REGRESSION ANALYSIS; SERUM;

ADIPOSE TISSUE; ANEMIA; BODY COMPOSITION; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE; ERYTHROPOIESIS; ERYTHROPOIETIN; FEMALE; FERRITINS; HEMOGLOBINS; HUMANS; INFLAMMATION; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; LEPTIN; MALE; MIDDLE AGED; ORGAN SIZE; POLYCYSTIC KIDNEY DISEASES; RENAL DIALYSIS; SWEDEN;

EID: 25644444060     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.06.004     Document Type: Article

References (25)

1. T. Drueke Hyporesponsiveness to recombinant human erythropoietin Nephrol Dial Transplant 16 suppl 7 2001 S25 S28
2. J. Axelsson, A. Rashid Qureshi, M.E. Suliman Truncal fat mass as a contributor to inflammation in end-stage renal disease Am J Clin Nutr 80 2004 1222 1229
3. J.S. Flier The adipocyte Storage depot or node on the energy information superhighway? Cell 80 1995 15 18
4. L.A. Tartaglia, M. Dembski, X. Weng Identification and expression cloning of a leptin receptor, OB-R Cell 83 1995 1263 1271
5. M. Ozata, I.C. Ozdemir, J. Licinio Human leptin deficiency caused by a missense mutation Multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects J Clin Endocrinol Metab 84 1999 3686 3695
6. P. Stenvinkel, O. Heimbürger, F. Lonnqvist Does the ob gene product leptin stimulate erythropoiesis in patients with chronic renal failure? Kidney Int 53 1998 1430 1431
7. B.D. Bennett, G.P. Solar, J.Q. Yuan A role for leptin and its cognate receptor in hematopoiesis Curr Biol 6 1996 1170 1180
8. A. Takeda, T. Toda, S. Shinohara Factors contributing to higher hematocrit levels in hemodialysis patients not receiving recombinant human erythropoietin Am J Kidney Dis 40 2002 104 109
9. N. Vaisman, T. Hahn, Y. Karov Changes in cytokine production and impaired hematopoiesis in patients with anorexia nervosa The effect of refeeding Cytokine 26 2004 255 261
10. F. Kokot, A. Wiecek, J. Mesjasz Influence of long-term recombinant human erythropoietin (rHuEpo) therapy on plasma leptin and neuropeptide Y concentration in haemodialysed uraemic patients Nephrol Dial Transplant 13 1998 1200 1205
11. A. Aguilera, M.A. Bajo, J.J. Diez Effects of human recombinant erythropoietin on inflammatory status in peritoneal dialysis patients Adv Perit Dial 18 2002 200 205
12. P. Stenvinkel, O. Heimbürger, F. Paultre Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure Kidney Int 55 1999 1899 1911
13. A. Marchlewska, P. Stenvinkel, B. Lindholm Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease Kidney Int 66 2004 46 50
14. Y. Zhang, R. Proenca, M. Maffei Positional cloning of the mouse obese gene and its human homologue Nature 372 1994 425 432
15. O. Heimbürger, F. Lonnqvist, A. Danielsson Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure J Am Soc Nephrol 8 1997 1423 1430
16. T. Madej, M.S. Boguski, S.H. Bryant Threading analysis suggests that the obese gene product may be a helical cytokine FEBS Lett 373 1995 13 18
17. J.A. Cioffi, A.W. Shafer, T.J. Zupancic Novel B219/OB receptor isoforms Possible role of leptin in hematopoiesis and reproduction Nat Med 2 1996 585 589
18. A.A. Mikhail, E.X. Beck, A. Shafer Leptin stimulates fetal and adult erythroid and myeloid development Blood 89 1997 1507 1512
19. D.N. Stamatiadis, J.L. Chan, R. Cogswell Elevated leptin fragments in renal failure correlate with BMI and haematopoiesis and are normalized by haemodialysis Clin Endocrinol (Oxf) 60 2004 434 441
20. F. Kokot, G. Samardzija, D. Klimek Intravenous single dose of erythropoietin (rHuEPO) does not influence plasma leptin concentration in hemodialyzed patients with chronic renal failure (CRF) Clin Nephrol 51 1999 389 391
21. S. Beddhu The body mass index paradox and an obesity, inflammation, and atherosclerosis syndrome in chronic kidney disease Semin Dial 17 2004 229 232
22. E.G. Lowrie, Z. Li, N. Ofsthun Body size, dialysis dose and death risk relationships among hemodialysis patients Kidney Int 62 2002 1891 1897
23. J. Malyszko, E. Zbroch, S. Wolczynski Leptin and serum erythropoietin in hemodialyzed and peritoneally dialyzed uremic patients during rHuEPO therapy Am J Nephrol 20 2000 180 186
24. A. Lammert, W. Kiess, A. Bottner Soluble leptin receptor represents the main leptin binding activity in human blood Biochem Biophys Res Commun 283 2001 982 988
25. R. Pecoits-Filho, L. Nordfors, O. Heimbürger Soluble leptin receptors and serum leptin in end-stage renal disease Relationship with inflammation and body composition Eur J Clin Invest 32 2002 811 817